- Home
- XBIT vs QUAD Comparison
XBIT vs QUAD Comparison
Compare XBIT & QUAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XBIT
- QUAD
- Stock Information
- Founded
- XBIT 2005
- QUAD 1971
- Country
- XBIT United States
- QUAD United States
- Employees
- XBIT N/A
- QUAD N/A
- Industry
- XBIT Pharmaceuticals and Biotechnology
- QUAD Publishing
- Sector
- XBIT Health Care
- QUAD Consumer Discretionary
- Exchange
- XBIT Nasdaq
- QUAD Nasdaq
- Market Cap
- XBIT 242.2M
- QUAD 233.2M
- IPO Year
- XBIT 2015
- QUAD 2010
- Fundamental
- Price
- XBIT $7.45
- QUAD $5.50
- Analyst Decision
- XBIT
- QUAD Strong Buy
- Analyst Count
- XBIT 0
- QUAD 2
- Target Price
- XBIT N/A
- QUAD $8.05
- AVG Volume (30 Days)
- XBIT 50.6K
- QUAD 153.0K
- Earning Date
- XBIT 11-07-2024
- QUAD 10-29-2024
- Dividend Yield
- XBIT N/A
- QUAD 3.64%
- EPS Growth
- XBIT N/A
- QUAD N/A
- EPS
- XBIT N/A
- QUAD N/A
- Revenue
- XBIT N/A
- QUAD $2,777,100,000.00
- Revenue This Year
- XBIT N/A
- QUAD N/A
- Revenue Next Year
- XBIT N/A
- QUAD N/A
- P/E Ratio
- XBIT N/A
- QUAD N/A
- Revenue Growth
- XBIT N/A
- QUAD N/A
- 52 Week Low
- XBIT $3.51
- QUAD $3.96
- 52 Week High
- XBIT $9.96
- QUAD $6.75
- Technical
- Relative Strength Index (RSI)
- XBIT 55.47
- QUAD 75.68
- Support Level
- XBIT $7.05
- QUAD $4.47
- Resistance Level
- XBIT $7.60
- QUAD $4.76
- Average True Range (ATR)
- XBIT 0.47
- QUAD 0.23
- MACD
- XBIT -0.02
- QUAD 0.10
- Stochastic Oscillator
- XBIT 71.43
- QUAD 97.17
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.
About QUAD Quad Graphics Inc
Quad/Graphics Inc provides print and marketing services to help customers market their products, services, and contents. The company operates in the commercial segment of the printing industry. It operates through three divisions. The United States print and related services segment consists of the company's American operations. Besides the complete set of print and marketing solutions, this segment also manufactures ink. The international segment includes the company's printing business in Europe and Latin America. The corporate segment is engaged in the general and administrative activities as well as associated costs. The company almost generates all its revenue from the American domestic market.